相关实验视频
Updated: Jan 9, 2026

02:26
Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
5.8K
在疼痛管理中准NMDA受体:通过piracetam重定向的治疗创新
Nidhi Dhama1, Aadesh Kumar2, Lakhan Singh1
1Faculty of Pharmacy, Swami Vivekanand, Subharti University , Meerut, Uttar Pradesh, 250005 , India.
Naunyn-Schmiedeberg's archives of pharmacology
|December 8, 2025
概括
皮拉通过调节N-甲基-D-酸盐 (NMDA) 受体和降低中心敏感性来治疗慢性疼痛. 本次审查强调了其作为一种新的治疗策略的有效性和安全性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- N-甲基-D-酸盐 (NMDA) 受体在疼痛调节和中央敏感化方面至关重要.
- 皮拉,以认知效应而闻名,影响谷氨酸的传播,影响疼痛通路.
研究的目的:
- 探索皮拉及其衍生物作为慢性疼痛NMDA受体活性的新型调节剂.
- 审查NMDA受体在疼痛中的作用和piracetam对中央敏感性的影响.
主要方法:
- 在主要科学数据库 (ScienceDirect,Scopus,PubMed,Web of Science) 中进行结构化搜索策略的叙事审查.
- 纳入标准侧重于NMDA受体在疼痛中的作用,piracetam对中央敏感性的影响,以及安全性.
主要成果:
- 皮拉调节NMDA受体,并起到降低中心敏感性的作用.
- 相对分析表明,与其他向NMDA受体的药物相比,其安全性和疗效较为有利.
结论:
- 皮拉及其衍生物具有作为针对NMDA受体的新型,更安全的止痛药的潜力.
- 需要进一步的研究来探索慢性疼痛管理的受体多样性和脱敏.
相关概念视频
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
517
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
517
Antiepileptic Drugs: Glutamate Antagonists
863
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
863
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
791
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
791

